Axplora Announces €6.5 Million Investment at Vizag Site
Axplora announced a significant investment at its Vizag site in India to expand production capacity and reinforce supply chain resilience.
Pharmazell
Axplora Aims to Make Pharmaceutical Supply Chains More Stable
Interview with Sylke Hassel, previous CEO of PharmaZell and current CEO of Axplora following the merger with Novasep.
Novasep‐PharmaZell Invests €7.3 Million in APIs
Financed in part by the French government’s France Relance plan, Novasep‐PharmaZell is investing €7.3 million in production of active pharmaceuticals (APIs) at its Mourenx, France, site.
Novasep and PharmaZell Conclude Merger
Following exclusive negotiations that started last September, German API specialist PharmaZell and French CDMO Novasep have merged as of Apr. 7. The combined group will have revenues of nearly €500 million and employ more than 2,000 people across 10 production and R&D sites – seven in Europe, two in India and one in the US.
Pharmazell and Novasep in Exclusive Merger Talks
German API specialist PharmaZell and French CDMO Novasep are in exclusive talks about a merger that the companies say would create a leading European platform in the attractive API manufacturing and CDMO space with a complementary set of differentiated technologies and highly diversified base of blue-chip pharma and biotech customers.
